Home  
  Glamour
Shots
 
  FAQ  
  Contacts  
  Press
Kit
 
  Authorized Bio  
  Trailer  
  Flash
Trailer
 
  Screenings  
  Downloads  
  Newsletter  
  Official PayPal SealOfficial PayPal Seal  

Columbia Laboratories revenues boost 11 percent to $32.

Columbia Laboratories’ revenues boost 11 percent to $32.5 million in 2014 Columbia Laboratories, Inc http://cialisprix.net/foire-aux-questions.html . , today announced economic results for the three – and twelve-month intervals ended December 31, 2014. During this transitional yr we restarted our medication development activities, significantly strengthened our management team, and generated a substantial amount of cash,’ mentioned Frank Condella, CEO. We look forward to initiating the Stage II study of COL-1077, a lidocaine bioadhesive gel designed as an acute use anesthetic for minimally invasive gynecological procedures, in the second quarter of 2015.

cialis 20 mg

Columbia Laboratories amends permit, supply agreement with Merck Serono for CRINONE Columbia Laboratories, Inc. provides amended its license and supply agreement with Merck Serono, a division of Merck KGaA . The early renewal of this contract through 2020 provides long-term stability for Columbia and surety of source for Merck Serono as they look to continue their expense in CRINONE globally. We anticipate continued positive cash flow from our core business as Merck Serono builds further product sales momentum for CRINONE.

  Member Area  
  LLX Internet Services  
  Cornerstone 28  
  The Valet  
  Underground Railroad  
  Event Gallery  
  Sponsors  
  Endorsements  
  Moon in Leo Prod.  
  Diamond And Sphinx  
  Chris Cory  
  Site Update Log